What is the typical dose of cephalexin (cephalexin) for wound infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cephalexin Dosing for Wound Infections

For wound infections in adults, cephalexin should be dosed at 500 mg orally four times daily (every 6 hours) for 7-10 days. 1, 2

Adult Dosing Recommendations

  • Standard dose: 500 mg orally four times daily (every 6 hours) is the recommended regimen for skin and soft tissue infections, including wound infections caused by methicillin-susceptible Staphylococcus aureus (MSSA). 1, 2

  • For mild to moderate infections, the dose may be reduced to 250 mg every 6 hours, though 500 mg four times daily provides more reliable coverage for wound infections. 1, 2

  • The FDA-approved dosage range for adults is 1-4 grams daily in divided doses, with the usual adult dose being 250 mg every 6 hours for most infections. 2

  • Duration of therapy is typically 7-10 days, depending on clinical response and severity of infection. 1

Pediatric Dosing Recommendations

  • For children with mild to moderate wound infections: 25-50 mg/kg/day divided into 4 doses (every 6 hours). 1, 2

  • For MSSA infections in children: 75-100 mg/kg/day divided into 3-4 doses provides more aggressive coverage when staphylococcal infection is confirmed or strongly suspected. 1, 2

  • The total daily dose may be divided and administered every 12 hours for skin and skin structure infections in patients over 1 year of age. 2

Clinical Considerations for Wound Infections

When Cephalexin is Appropriate

  • Cephalexin is effective for uncomplicated wound infections caused by MSSA and streptococci. 3, 4

  • A randomized controlled trial demonstrated that cephalexin 500 mg four times daily was non-inferior to intravenous cefazolin for uncomplicated mild-moderate skin and soft tissue infections, with treatment failure rates of only 4.2% at 72 hours. 3

Important Limitations

  • Cephalexin is completely ineffective against MRSA and should not be used if methicillin-resistant S. aureus is suspected or confirmed. 1

  • Cephalexin has poor activity against Haemophilus influenzae, Moraxella catarrhalis, and is completely ineffective against Pseudomonas aeruginosa. 1

  • For bite wounds (animal or human), cephalexin alone is NOT recommended as first-line therapy because it misses important pathogens like Pasteurella multocida (animal bites) and Eikenella corrodens (human bites), and has inadequate anaerobic coverage. 5

Special Wound Types Requiring Alternative Antibiotics

  • Animal bite wounds: Use amoxicillin-clavulanate 875/125 mg twice daily as first-line therapy to cover both aerobic and anaerobic bacteria. 5

  • Human bite wounds: Use amoxicillin-clavulanate 875/125 mg twice daily or ampicillin-sulbactam 1.5-3.0 g IV every 6 hours to cover Eikenella corrodens and anaerobes. 5

  • High-risk wounds (immunocompromised patients, asplenic, advanced liver disease, hand/face injuries, or wounds penetrating periosteum/joint capsule) require preemptive antimicrobial therapy for 3-5 days with agents covering both aerobes and anaerobes. 5

Penicillin Allergy Considerations

  • Cephalexin can be used in patients with non-severe penicillin allergy, but is contraindicated in patients with a history of anaphylaxis, angioedema, or urticaria to penicillins. 1

References

Guideline

Cephalexin Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.